🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Abbreviated Title: Neoadjuvant FOLFIRINOX combined with Pembrolizumab follo...
Status
Recruiting
Location
Baylor College of Medicine
Start Date
2022-08-31
Trial ID
NCT05132504
Treatments Being Tested
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive tumor with a...
Status
Completed
Location
Zhejiang Province Cancer Hospital
Start Date
2022-07-01
Trial ID
NCT06378580
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of mFOLFIRINOX plus r...
Status
Recruiting
Location
Shanghai Cancer Center
Start Date
2024-01-10
Trial ID
NCT06149689
Treatments Being Tested
This research is being done to evaluate the safety and effectiveness of the...
Status
Terminated
Location
Massachusetts General Hospital Cancer Center
Start Date
2022-08-09
Trial ID
NCT05417386
To assess the ability of a combination of updated and approved modalities i...
Status
Terminated
Location
Southwestern Regional Medical Center, Inc.
Start Date
2013-01
Trial ID
NCT01760694
Treatments Being Tested
The goal of this open-label randomized, multicenter, comparative phase II t...
Status
Recruiting
Location
Institut de Cancérologie de l'Ouest
Start Date
2024-07-23
Trial ID
NCT06333314
Treatments Being Tested
The study is designed to test the hypothesis that the clinical complete res...
Status
Not Yet Recruiting
Location
Fudan University Shanghai Cancer Cencer
Start Date
2020-06-22
Trial ID
NCT04443543
The purpose of this study is to evaluate the efficacy of mFOLFIRINOX plus r...
Status
Recruiting
Location
Shanghai Cancer Center
Start Date
2024-04-01
Trial ID
NCT06249321
Treatments Being Tested
The goal of this multicenter randomized controlled phase III trial is to co...
Status
Recruiting
Location
SahlgrenskaUH
Start Date
2023-10-18
Trial ID
NCT06714604
Treatments Being Tested
Ampullary adenocarcinoma (AMPAC) is a rare cancer (0.2% of digestive cancer...
Status
Recruiting
Location
CHU Dijon Bourgogne
Start Date
2025-07-02
Trial ID
NCT06813976